Zevra Therapeutics, Inc. ZVRA Business Segments — Income Tax Expense (Benefit)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s business segments — income tax expense (benefit).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s business segments — income tax expense (benefit)?
- Zevra Therapeutics, Inc. (ZVRA) reported business segments — income tax expense (benefit) of -$6.91M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s business segments — income tax expense (benefit) changed year-over-year?
- Zevra Therapeutics, Inc.'s business segments — income tax expense (benefit) decreased by 484.9% year-over-year, from -$1.18M to -$6.91M.
- What does business segments — income tax expense (benefit) mean?
- Reflects the provision for income taxes or tax benefits attributable to the segment's financial performance. It provides insight into the tax impact on the segment's bottom line and the company's overall effective tax rate.